Stay updated on CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial
Sign up to get notified when there's something new on the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page.

Latest updates to the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page
- Check3 days agoChange DetectedThe trial’s record history adds a recent version covering study status and contact/location information, while older version entries shift in the list. An NIH notice about terminology during the transition to “Super Intelligence” also appears on the page.SummaryDifference0.2%

- Check10 days agoChange DetectedA new record version submitted on October 14, 2026, updates the study status and contacts/locations.SummaryDifference0.1%

- Check17 days agoChange DetectedThe record history now includes a study-status update dated 2026-10-07 and a contacts/locations revision dated 2026-10-06, alongside an updated site revision label.SummaryDifference0.1%

- Check24 days agoChange DetectedOn 2026-09-29, the history adds new Contacts/Locations and Study Status sections to the study record; on 2026-09-26, entries labeled 349 and 350 were added to the history.SummaryDifference0.1%

- Check31 days agoChange DetectedOn 2026-09-23, the record history adds entries for Contacts/Locations and Study Status (with a 2026-09-22 reference and the number 348), and an entry dated 2026-09-11 was removed. This reflects updated site information and the latest status in the study's record history.SummaryDifference0.1%

- Check38 days agoChange DetectedThe history view adds navigation labels such as Find contact information, Contacts/Locations, and Study Status, and shows a site revision to Revision: v3.7.0, while removing the older Find Contact Information label and Revision: v3.6.6.SummaryDifference0.2%

Stay in the know with updates to CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page.